Granowitz Craig B
Lexicon Pharmaceuticals, Inc. · SVP
Granowitz Craig B is listed in public filings as officer: SVP, Chief Medical Officer. This Granowitz Craig B insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Lexicon Pharmaceuticals, Inc. (LXRX). Investors use Granowitz Craig B's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| --35.8k shares | Grant / ExerciseFeb 28, 2026 | Disclosure amount unavailable35.8k shares | -- | -- | |
| --74.2k shares | Grant / ExerciseFeb 28, 2026 | Disclosure amount unavailable74.2k shares | -- | -- | |
| --404.5k shares | Grant / ExerciseFeb 28, 2026 | Disclosure amount unavailable202.3k shares | -- | -- | |
| $475k323.4k shares | Grant / ExerciseFeb 28, 2026 | $160.4K109.1k shares | $1.47 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $712k519.9k shares | Grant / ExerciseFeb 12, 2026 | $712.3K519.9k shares | $1.37 | -- | |
| --346.6k shares | Grant / ExerciseFeb 12, 2026 | Disclosure amount unavailable346.6k shares | -- | -- | |
| --27.9k shares | Grant / ExerciseFeb 28, 2025 | Disclosure amount unavailable27.9k shares | -- | -- | |
| --35.8k shares | Grant / ExerciseFeb 28, 2025 | Disclosure amount unavailable35.8k shares | -- | -- | |
| --148.5k shares | Grant / ExerciseFeb 28, 2025 | Disclosure amount unavailable74.2k shares | -- | -- | |
| $81k120.3k shares | Grant / ExerciseFeb 28, 2025 | $43.8K65.3k shares | $0.67 | -- | |
| $633k910.2k shares | Grant / ExerciseFeb 13, 2025 | $632.6K910.2k shares | $0.695 | -- | |
| --606.8k shares | Grant / ExerciseFeb 13, 2025 | Disclosure amount unavailable606.8k shares | -- | -- |